LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.

Smeets, Ralf / Gerhards, Frank / Stein, Jamal M / Stein, Jamal / Paz, Rui Miguel Pereira / Vogt, Stephan / Pautke, Christoph / Weitz, Jochen / Kolk, Andreas

Journal of biomedical materials research. Part A

2011  Volume 96, Issue 1, Page(s) 177–185

Abstract: Topical thrombins are locally active hemostatic agents that can be used to minimize blood loss during any surgery. The aim of this study was to design and investigate a thrombin-containing biodegradable hemostyptic device with an optimized drug release ... ...

Abstract Topical thrombins are locally active hemostatic agents that can be used to minimize blood loss during any surgery. The aim of this study was to design and investigate a thrombin-containing biodegradable hemostyptic device with an optimized drug release profile to promote local blood clot formation. It is effective with ongoing systemic antithrombotic therapy and can be used in all types of bone-related surgery, for example, in dental surgery. Thrombin-loaded poly(D,L-lactide-co-glycolide) microspheres were synthesized by means of complex (w/o/w) emulsion evaporation method. The resulting enzyme activity of the serine-protease thrombin was verified by the specific chromogenic substrate S-2238. The thrombin release profile depended on four factors: (1) thrombin dosage, (2) polymer concentration in the o-phase, (3) phase quotient w1:0 in the primary emulsion, and (4) the addition of pore-introducing agents. A collagenous sponge containing thrombin-loaded microspheres by means of lyophilization was developed. The impact of several production factors of the (w1/o/w2) solvent evaporation method to optimize thrombin encapsulation, morphology of the spheres, and desired drug release profile have been investigated. The in vitro thrombin release was dependent on the polymer-to-oil phase ratio, the polymer concentration, and the type of solvent and polymer. The porosity of the spheres and release rate of the active agent were enhanced by increasing the inner aqueous w1 phase. With this study, a new biodegradable hemostyptic device could be verified and established for a potentially safe and locally controlled thrombin release to manage postsurgical hemorrhage in patients undergoing anticoagulant therapy.
MeSH term(s) Absorbable Implants ; Biocompatible Materials/chemistry ; Biocompatible Materials/metabolism ; Drug Carriers/chemical synthesis ; Drug Carriers/chemistry ; Drug Carriers/metabolism ; Hemostatics/chemistry ; Hemostatics/metabolism ; Humans ; Hydrogen-Ion Concentration ; Lactic Acid/chemistry ; Materials Testing ; Microscopy, Electron, Scanning ; Microspheres ; Particle Size ; Polyglycolic Acid/chemistry ; Solvents ; Thrombin/chemistry ; Thrombin/metabolism
Chemical Substances Biocompatible Materials ; Drug Carriers ; Hemostatics ; Solvents ; polylactic acid-polyglycolic acid copolymer ; Polyglycolic Acid (26009-03-0) ; Lactic Acid (33X04XA5AT) ; Thrombin (EC 3.4.21.5)
Language English
Publishing date 2011-01
Publishing country United States
Document type Evaluation Studies ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 2099989-6
ISSN 1552-4965 ; 1549-3296 ; 0021-9304
ISSN (online) 1552-4965
ISSN 1549-3296 ; 0021-9304
DOI 10.1002/jbm.a.32970
Shelf mark
Zs.A 6195: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top